October 25, 2017
Michael Narachi, CEO for Orexigen.
Stories this photo appears in:
PHARMA: Unable to Go It Alone, Co. Pursues Strategic Alternatives
Diet pill maker Orexigen Therapeutics, one of San Diego’s struggling public companies, may soon auction itself off to the highest bidder in an attempt to fortify its finances.